Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

Tumor cell-secreted PLD increases tumor stemness by senescence-mediated communication with microenvironment.

Muñoz-Galván S, Lucena-Cacace A, Perez M, Otero-Albiol D, Gomez-Cambronero J, Carnero A.

Oncogene. 2018 Oct 10. doi: 10.1038/s41388-018-0527-2. [Epub ahead of print]

PMID:
30305726
2.

MAP17 (PDZK1IP1) and pH2AX are potential predictive biomarkers for rectal cancer treatment efficacy.

Rivero M, Peinado-Serrano J, Muñoz-Galvan S, Espinosa-Sánchez A, Suarez-Martinez E, Felipe-Abrio B, Fernández-Fernández MC, Ortiz MJ, Carnero A.

Oncotarget. 2018 Aug 31;9(68):32958-32971. doi: 10.18632/oncotarget.26010. eCollection 2018 Aug 31.

3.

MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma.

Ferrer I, Quintanal-Villalonga Á, Molina-Pinelo S, Garcia-Heredia JM, Perez M, Suárez R, Ponce-Aix S, Paz-Ares L, Carnero A.

J Exp Clin Cancer Res. 2018 Aug 17;37(1):195. doi: 10.1186/s13046-018-0871-7.

4.

Histology-dependent prognostic role of pERK and p53 protein levels in early-stage non-small cell lung cancer.

Quintanal-Villalonga Á, Mediano M, Ferrer I, Meléndez R, Carranza-Carranza A, Suárez R, Carnero A, Molina-Pinelo S, Paz-Ares L.

Oncotarget. 2018 Apr 13;9(28):19945-19960. doi: 10.18632/oncotarget.24977. eCollection 2018 Apr 13.

5.

Dr. Jekyll and Mr. Hyde: MAP17's up-regulation, a crosspoint in cancer and inflammatory diseases.

García-Heredia JM, Carnero A.

Mol Cancer. 2018 Apr 12;17(1):80. doi: 10.1186/s12943-018-0828-7. Review. No abstract available.

6.

Risk for interspecies transmission of zoonotic pathogens during poultry processing and pork production in Peru: A qualitative study.

Carnero AM, Kitayama K, Diaz DA, Garvich M, Angulo N, Cama VA, Gilman RH, Bayer AM.

Zoonoses Public Health. 2018 Aug;65(5):528-539. doi: 10.1111/zph.12463. Epub 2018 Mar 30.

PMID:
29602269
7.

NUMB and NUMBL differences in gene regulation.

García-Heredia JM, Carnero A.

Oncotarget. 2018 Jan 11;9(10):9219-9234. doi: 10.18632/oncotarget.24186. eCollection 2018 Feb 6.

8.

The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction.

Quintanal-Villalonga Á, Ojeda-Márquez L, Marrugal Á, Yagüe P, Ponce-Aix S, Salinas A, Carnero A, Ferrer I, Molina-Pinelo S, Paz-Ares L.

Sci Rep. 2018 Feb 5;8(1):2394. doi: 10.1038/s41598-018-20570-3.

9.

Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer.

Verdugo-Sivianes EM, Navas L, Molina-Pinelo S, Ferrer I, Quintanal-Villalonga A, Peinado J, Garcia-Heredia JM, Felipe-Abrio B, Muñoz-Galvan S, Marin JJ, Montuenga L, Paz-Ares L, Carnero A.

Oncotarget. 2017 Oct 26;8(62):105196-105210. doi: 10.18632/oncotarget.22111. eCollection 2017 Dec 1.

10.

NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis.

Lucena-Cacace A, Otero-Albiol D, Jiménez-García MP, Peinado-Serrano J, Carnero A.

Oncotarget. 2017 Aug 28;8(59):99514-99530. doi: 10.18632/oncotarget.20577. eCollection 2017 Nov 21.

11.

The cargo protein MAP17 (PDZK1IP1) regulates the immune microenvironment.

García-Heredia JM, Carnero A.

Oncotarget. 2017 Oct 6;8(58):98580-98597. doi: 10.18632/oncotarget.21651. eCollection 2017 Nov 17.

12.

NAMPT Is a Potent Oncogene in Colon Cancer Progression that Modulates Cancer Stem Cell Properties and Resistance to Therapy through Sirt1 and PARP.

Lucena-Cacace A, Otero-Albiol D, Jiménez-García MP, Muñoz-Galvan S, Carnero A.

Clin Cancer Res. 2018 Mar 1;24(5):1202-1215. doi: 10.1158/1078-0432.CCR-17-2575. Epub 2017 Dec 4.

PMID:
29203587
13.

Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS).

Martin-Broto J, Redondo A, Valverde C, Vaz MA, Mora J, Garcia Del Muro X, Gutierrez A, Tous C, Carnero A, Marcilla D, Carranza A, Sancho P, Martinez-Trufero J, Diaz-Beveridge R, Cruz J, Encinas V, Taron M, Moura DS, Luna P, Hindi N, Lopez-Pousa A.

Ann Oncol. 2017 Dec 1;28(12):2994-2999. doi: 10.1093/annonc/mdx536.

PMID:
29045512
14.

Inflammation and stem markers association to PIM1/PIM2 kinase-induced tumors in breast and uterus.

Jiménez-García MP, Lucena-Cacace A, Robles-Frías MJ, Ferrer I, Narlik-Grassow M, Blanco-Aparicio C, Carnero A.

Oncotarget. 2017 Jul 22;8(35):58872-58886. doi: 10.18632/oncotarget.19438. eCollection 2017 Aug 29.

15.

Prognostic relevance of Src activation in stage II-III colon cancer.

Martínez-Pérez J, Lopez-Calderero I, Saez C, Benavent M, Limon ML, Gonzalez-Exposito R, Soldevilla B, Riesco-Martínez MC, Salamanca J, Carnero A, Garcia-Carbonero R.

Hum Pathol. 2017 Sep;67:119-125. doi: 10.1016/j.humpath.2017.05.025. Epub 2017 Jun 7.

PMID:
28601656
16.

The Cargo Protein MAP17 (PDZK1IP1) Regulates the Cancer Stem Cell Pool Activating the Notch Pathway by Abducting NUMB.

Garcia-Heredia JM, Lucena-Cacace A, Verdugo-Sivianes EM, Pérez M, Carnero A.

Clin Cancer Res. 2017 Jul 15;23(14):3871-3883. doi: 10.1158/1078-0432.CCR-16-2358. Epub 2017 Feb 2.

17.

Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src.

Perez M, Lucena-Cacace A, Marín-Gómez LM, Padillo-Ruiz J, Robles-Frias MJ, Saez C, Garcia-Carbonero R, Carnero A.

Oncotarget. 2016 Nov 22;7(47):78219. doi: 10.18632/oncotarget.13482. No abstract available.

18.

The role of PIM1/PIM2 kinases in tumors of the male reproductive system.

Jiménez-García MP, Lucena-Cacace A, Robles-Frías MJ, Narlik-Grassow M, Blanco-Aparicio C, Carnero A.

Sci Rep. 2016 Nov 30;6:38079. doi: 10.1038/srep38079.

19.

Unstable Malaria Transmission in the Southern Peruvian Amazon and Its Association with Gold Mining, Madre de Dios, 2001-2012.

Sanchez JF, Carnero AM, Rivera E, Rosales LA, Baldeviano GC, Asencios JL, Edgel KA, Vinetz JM, Lescano AG.

Am J Trop Med Hyg. 2017 Feb 8;96(2):304-311. doi: 10.4269/ajtmh.16-0030. Epub 2016 Nov 22.

20.

Plagiarism, Cheating and Research Integrity: Case Studies from a Masters Program in Peru.

Carnero AM, Mayta-Tristan P, Konda KA, Mezones-Holguin E, Bernabe-Ortiz A, Alvarado GF, Canelo-Aybar C, Maguiña JL, Segura ER, Quispe AM, Smith ES, Bayer AM, Lescano AG.

Sci Eng Ethics. 2017 Aug;23(4):1183-1197. doi: 10.1007/s11948-016-9820-z. Epub 2016 Nov 15.

21.

Genome-Wide miRNA Screening for Genes Bypassing Oncogene-Induced Senescence.

Guijarro MV, Carnero A.

Methods Mol Biol. 2017;1534:53-68.

PMID:
27812867
22.

Subcellular localisation of pMEK has a different prognosis in locally advanced head and neck cancer treated with concomitant radiochemotherapy.

Gomez-Millan J, Pajares B, Perez-Villa L, Carnero A, Alvarez M, De Luque V, Rivas F, Trigo JM, Toledo MD, Alba E, Medina JA.

BMC Cancer. 2016 Oct 28;16(1):829.

23.

The Cytoskeletal Adapter Protein Spinophilin Regulates Invadopodia Dynamics and Tumor Cell Invasion in Glioblastoma.

Cheerathodi M, Avci NG, Guerrero PA, Tang LK, Popp J, Morales JE, Chen Z, Carnero A, Lang FF, Ballif BA, Rivera GM, McCarty JH.

Mol Cancer Res. 2016 Dec;14(12):1277-1287. Epub 2016 Sep 21.

24.

Numb-like (NumbL) downregulation increases tumorigenicity, cancer stem cell-like properties and resistance to chemotherapy.

García-Heredia JM, Verdugo Sivianes EM, Lucena-Cacace A, Molina-Pinelo S, Carnero A.

Oncotarget. 2016 Sep 27;7(39):63611-63628. doi: 10.18632/oncotarget.11553.

25.

Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1).

Perez M, Peinado-Serrano J, Garcia-Heredia JM, Felipe-Abrio I, Tous C, Ferrer I, Martin-Broto J, Saez C, Carnero A.

Oncotarget. 2016 Oct 11;7(41):67033-67046. doi: 10.18632/oncotarget.11475.

26.

IL-11 and CCL-1: Novel Protein Diagnostic Biomarkers of Lung Adenocarcinoma in Bronchoalveolar Lavage Fluid (BALF).

Pastor MD, Nogal A, Molina-Pinelo S, Quintanal-Villalonga Á, Meléndez R, Ferrer I, Romero-Romero B, De Miguel MJ, López-Campos JL, Corral J, García-Carboner R, Carnero A, Paz-Ares L.

J Thorac Oncol. 2016 Dec;11(12):2183-2192. doi: 10.1016/j.jtho.2016.07.026. Epub 2016 Aug 12.

27.

The cancer stem-cell signaling network and resistance to therapy.

Carnero A, Garcia-Mayea Y, Mir C, Lorente J, Rubio IT, LLeonart ME.

Cancer Treat Rev. 2016 Sep;49:25-36. doi: 10.1016/j.ctrv.2016.07.001. Epub 2016 Jul 9. Review.

PMID:
27434881
28.

The hypoxic microenvironment: A determinant of cancer stem cell evolution.

Carnero A, Lleonart M.

Bioessays. 2016 Jul;38 Suppl 1:S65-74. doi: 10.1002/bies.201670911. Review.

PMID:
27417124
29.

Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer.

Molina-Pinelo S, Salinas A, Moreno-Mata N, Ferrer I, Suarez R, Andrés-León E, Rodríguez-Paredes M, Gutekunst J, Jantus-Lewintre E, Camps C, Carnero A, Paz-Ares L.

Oncotarget. 2016 Jul 15;9(4):4395-4410. doi: 10.18632/oncotarget.10611. eCollection 2018 Jan 12.

30.

Beta-cell function and insulin resistance among Peruvian adolescents with type 2 diabetes.

Zelada H, Carnero AM, Miranda-Hurtado C, Condezo-Aliaga D, Loza-Munarriz C, Aro-Guardia P, Manrique H.

J Clin Transl Endocrinol. 2016 May 16;5:15-20. doi: 10.1016/j.jcte.2016.05.003. eCollection 2016 Sep.

31.

Phosphorylation of gH2AX as a novel prognostic biomarker for laryngoesophageal dysfunction-free survival.

de Miguel-Luken MJ, Chaves-Conde M, Quintana B, Menoyo A, Tirado I, de Miguel-Luken V, Pachón J, Chinchón D, Suarez V, Carnero A.

Oncotarget. 2016 May 31;7(22):31723-37. doi: 10.18632/oncotarget.9172.

32.

Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src.

Perez M, Lucena-Cacace A, Marín-Gómez LM, Padillo-Ruiz J, Robles-Frias MJ, Saez C, Garcia-Carbonero R, Carnero A.

Oncotarget. 2016 May 31;7(22):33111-24. doi: 10.18632/oncotarget.8880. Erratum in: Oncotarget. 2016 Nov 22;7(47):78219.

33.

Pupillary Light Reflexes are Associated with Autonomic Dysfunction in Bolivian Diabetics But Not Chagas Disease Patients.

Halperin A, Pajuelo M, Tornheim JA, Vu N, Carnero AM, Galdos-Cardenas G, Ferrufino L, Camacho M, Justiniano J, Colanzi R, Bowman NM, Morris T, MacDougall H, Bern C, Moore ST, Gilman RH; Chagas Working Group in Bolivia and Peru.

Am J Trop Med Hyg. 2016 Jun 1;94(6):1290-8. doi: 10.4269/ajtmh.14-0775. Epub 2016 Apr 4.

34.

A genetic view of laryngeal cancer heterogeneity.

de Miguel-Luken MJ, Chaves-Conde M, Carnero A.

Cell Cycle. 2016 May 2;15(9):1202-12. doi: 10.1080/15384101.2016.1156275. Epub 2016 Mar 3. Review.

35.

Need to consider non-randomised evidence to assess the effectiveness and safety of interventions promoting maternal awareness of decreased fetal movements.

Carnero AM.

BJOG. 2016 May;123(6):899. doi: 10.1111/1471-0528.13865. Epub 2016 Feb 5. No abstract available.

36.

Designing a broad-spectrum integrative approach for cancer prevention and treatment.

Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin ARMR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, Bishayee A, Blain SW, Block PB, Boosani CS, Carey TE, Carnero A, Carotenuto M, Casey SC, Chakrabarti M, Chaturvedi R, Chen GZ, Chen H, Chen S, Chen YC, Choi BK, Ciriolo MR, Coley HM, Collins AR, Connell M, Crawford S, Curran CS, Dabrosin C, Damia G, Dasgupta S, DeBerardinis RJ, Decker WK, Dhawan P, Diehl AME, Dong JT, Dou QP, Drew JE, Elkord E, El-Rayes B, Feitelson MA, Felsher DW, Ferguson LR, Fimognari C, Firestone GL, Frezza C, Fujii H, Fuster MM, Generali D, Georgakilas AG, Gieseler F, Gilbertson M, Green MF, Grue B, Guha G, Halicka D, Helferich WG, Heneberg P, Hentosh P, Hirschey MD, Hofseth LJ, Holcombe RF, Honoki K, Hsu HY, Huang GS, Jensen LD, Jiang WG, Jones LW, Karpowicz PA, Keith WN, Kerkar SP, Khan GN, Khatami M, Ko YH, Kucuk O, Kulathinal RJ, Kumar NB, Kwon BS, Le A, Lea MA, Lee HY, Lichtor T, Lin LT, Locasale JW, Lokeshwar BL, Longo VD, Lyssiotis CA, MacKenzie KL, Malhotra M, Marino M, Martinez-Chantar ML, Matheu A, Maxwell C, McDonnell E, Meeker AK, Mehrmohamadi M, Mehta K, Michelotti GA, Mohammad RM, Mohammed SI, Morre DJ, Muralidhar V, Muqbil I, Murphy MP, Nagaraju GP, Nahta R, Niccolai E, Nowsheen S, Panis C, Pantano F, Parslow VR, Pawelec G, Pedersen PL, Poore B, Poudyal D, Prakash S, Prince M, Raffaghello L, Rathmell JC, Rathmell WK, Ray SK, Reichrath J, Rezazadeh S, Ribatti D, Ricciardiello L, Robey RB, Rodier F, Rupasinghe HPV, Russo GL, Ryan EP, Samadi AK, Sanchez-Garcia I, Sanders AJ, Santini D, Sarkar M, Sasada T, Saxena NK, Shackelford RE, Shantha Kumara HMC, Sharma D, Shin DM, Sidransky D, Siegelin MD, Signori E, Singh N, Sivanand S, Sliva D, Smythe C, Spagnuolo C, Stafforini DM, Stagg J, Subbarayan PR, Sundin T, Talib WH, Thompson SK, Tran PT, Ungefroren H, Vander Heiden MG, Venkateswaran V, Vinay DS, Vlachostergios PJ, Wang Z, Wellen KE, Whelan RL, Yang ES, Yang H, Yang X, Yaswen P, Yedjou C, Yin X, Zhu J, Zollo M.

Semin Cancer Biol. 2015 Dec;35 Suppl:S276-S304. doi: 10.1016/j.semcancer.2015.09.007. Review.

37.

Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA.

Perez M, Muñoz-Galván S, Jiménez-García MP, Marín JJ, Carnero A.

Oncotarget. 2015 Dec 1;6(38):40557-74. doi: 10.18632/oncotarget.5829.

38.

Decoding Warburg's hypothesis: tumor-related mutations in the mitochondrial respiratory chain.

Garcia-Heredia JM, Carnero A.

Oncotarget. 2015 Dec 8;6(39):41582-99. doi: 10.18632/oncotarget.6057. Review.

39.

Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors.

Ferrer I, Verdugo-Sivianes EM, Castilla MA, Melendez R, Marin JJ, Muñoz-Galvan S, Lopez-Guerra JL, Vieites B, Ortiz-Gordillo MJ, De León JM, Praena-Fernandez JM, Perez M, Palacios J, Carnero A.

Oncogene. 2016 May;35(21):2777-88. doi: 10.1038/onc.2015.341. Epub 2015 Sep 21.

PMID:
26387546
40.

High casein kinase 1 epsilon levels are correlated with better prognosis in subsets of patients with breast cancer.

Lopez-Guerra JL, Verdugo-Sivianes EM, Otero-Albiol D, Vieites B, Ortiz-Gordillo MJ, De León JM, Praena-Fernandez JM, Marin JJ, Carnero A.

Oncotarget. 2015 Oct 6;6(30):30343-56. doi: 10.18632/oncotarget.4850.

41.

Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.

Goodson WH 3rd, Lowe L, Carpenter DO, Gilbertson M, Manaf Ali A, Lopez de Cerain Salsamendi A, Lasfar A, Carnero A, Azqueta A, Amedei A, Charles AK, Collins AR, Ward A, Salzberg AC, Colacci A, Olsen AK, Berg A, Barclay BJ, Zhou BP, Blanco-Aparicio C, Baglole CJ, Dong C, Mondello C, Hsu CW, Naus CC, Yedjou C, Curran CS, Laird DW, Koch DC, Carlin DJ, Felsher DW, Roy D, Brown DG, Ratovitski E, Ryan EP, Corsini E, Rojas E, Moon EY, Laconi E, Marongiu F, Al-Mulla F, Chiaradonna F, Darroudi F, Martin FL, Van Schooten FJ, Goldberg GS, Wagemaker G, Nangami GN, Calaf GM, Williams G, Wolf GT, Koppen G, Brunborg G, Lyerly HK, Krishnan H, Ab Hamid H, Yasaei H, Sone H, Kondoh H, Salem HK, Hsu HY, Park HH, Koturbash I, Miousse IR, Scovassi AI, Klaunig JE, Vondráček J, Raju J, Roman J, Wise JP Sr, Whitfield JR, Woodrick J, Christopher JA, Ochieng J, Martinez-Leal JF, Weisz J, Kravchenko J, Sun J, Prudhomme KR, Narayanan KB, Cohen-Solal KA, Moorwood K, Gonzalez L, Soucek L, Jian L, D'Abronzo LS, Lin LT, Li L, Gulliver L, McCawley LJ, Memeo L, Vermeulen L, Leyns L, Zhang L, Valverde M, Khatami M, Romano MF, Chapellier M, Williams MA, Wade M, Manjili MH, Lleonart ME, Xia M, Gonzalez MJ, Karamouzis MV, Kirsch-Volders M, Vaccari M, Kuemmerle NB, Singh N, Cruickshanks N, Kleinstreuer N, van Larebeke N, Ahmed N, Ogunkua O, Krishnakumar PK, Vadgama P, Marignani PA, Ghosh PM, Ostrosky-Wegman P, Thompson PA, Dent P, Heneberg P, Darbre P, Sing Leung P, Nangia-Makker P, Cheng QS, Robey RB, Al-Temaimi R, Roy R, Andrade-Vieira R, Sinha RK, Mehta R, Vento R, Di Fiore R, Ponce-Cusi R, Dornetshuber-Fleiss R, Nahta R, Castellino RC, Palorini R, Abd Hamid R, Langie SA, Eltom SE, Brooks SA, Ryeom S, Wise SS, Bay SN, Harris SA, Papagerakis S, Romano S, Pavanello S, Eriksson S, Forte S, Casey SC, Luanpitpong S, Lee TJ, Otsuki T, Chen T, Massfelder T, Sanderson T, Guarnieri T, Hultman T, Dormoy V, Odero-Marah V, Sabbisetti V, Maguer-Satta V, Rathmell WK, Engström W, Decker WK, Bisson WH, Rojanasakul Y, Luqmani Y, Chen Z, Hu Z.

Carcinogenesis. 2015 Jun;36 Suppl 1:S254-96. doi: 10.1093/carcin/bgv039. Review. Erratum in: Carcinogenesis. 2016 Mar;37(3):344.

42.

Disruptive chemicals, senescence and immortality.

Carnero A, Blanco-Aparicio C, Kondoh H, Lleonart ME, Martinez-Leal JF, Mondello C, Scovassi AI, Bisson WH, Amedei A, Roy R, Woodrick J, Colacci A, Vaccari M, Raju J, Al-Mulla F, Al-Temaimi R, Salem HK, Memeo L, Forte S, Singh N, Hamid RA, Ryan EP, Brown DG, Wise JP Sr, Wise SS, Yasaei H.

Carcinogenesis. 2015 Jun;36 Suppl 1:S19-37. doi: 10.1093/carcin/bgv029. Review.

43.

Outbreak of Cutaneous Leishmaniasis in Peruvian Military Personnel Undertaking Training Activities in the Amazon Basin, 2010.

Oré M, Sáenz E, Cabrera R, Sanchez JF, De Los Santos MB, Lucas CM, Núñez JH, Edgel KA, Sopan J, Fernández J, Carnero AM, Baldeviano GC, Arrasco JC, Graf PC, Lescano AG.

Am J Trop Med Hyg. 2015 Aug;93(2):340-6. doi: 10.4269/ajtmh.15-0107. Epub 2015 Jun 15.

44.

Therapeutic targeting of replicative immortality.

Yaswen P, MacKenzie KL, Keith WN, Hentosh P, Rodier F, Zhu J, Firestone GL, Matheu A, Carnero A, Bilsland A, Sundin T, Honoki K, Fujii H, Georgakilas AG, Amedei A, Amin A, Helferich B, Boosani CS, Guha G, Ciriolo MR, Chen S, Mohammed SI, Azmi AS, Bhakta D, Halicka D, Niccolai E, Aquilano K, Ashraf SS, Nowsheen S, Yang X.

Semin Cancer Biol. 2015 Dec;35 Suppl:S104-S128. doi: 10.1016/j.semcancer.2015.03.007. Epub 2015 Apr 11. Review.

45.

MAP17 (PDZKIP1) Expression Determines Sensitivity to the Proteasomal Inhibitor Bortezomib by Preventing Cytoprotective Autophagy and NFκB Activation in Breast Cancer.

Muñoz-Galván S, Gutierrez G, Perez M, Carnero A.

Mol Cancer Ther. 2015 Jun;14(6):1454-65. doi: 10.1158/1535-7163.MCT-14-1053. Epub 2015 Apr 2.

46.

MAP17 (PDZKIP1) as a novel prognostic biomarker for laryngeal cancer.

de Miguel-Luken MJ, Chaves-Conde M, de Miguel-Luken V, Muñoz-Galván S, López-Guerra JL, Mateos JC, Pachón J, Chinchón D, Suarez V, Carnero A.

Oncotarget. 2015 May 20;6(14):12625-36.

47.

Gene expression profile predictive of response to chemotherapy in metastatic colorectal cancer.

Estevez-Garcia P, Rivera F, Molina-Pinelo S, Benavent M, Gómez J, Limón ML, Pastor MD, Martinez-Perez J, Paz-Ares L, Carnero A, Garcia-Carbonero R.

Oncotarget. 2015 Mar 20;6(8):6151-9.

48.

Efficacy of an alphabaculovirus-based biological insecticide for control of Chrysodeixis chalcites (Lepidoptera: Noctuidae) on tomato and banana crops.

Simón O, Bernal A, Williams T, Carnero A, Hernández-Suárez E, Muñoz D, Caballero P.

Pest Manag Sci. 2015 Dec;71(12):1623-30. doi: 10.1002/ps.3969. Epub 2015 Jan 21.

PMID:
25534715
49.

Genetic modification of hypoxia signaling in animal models and its effect on cancer.

García-Heredia JM, Felipe-Abrio B, Cano DA, Carnero A.

Clin Transl Oncol. 2015 Feb;17(2):90-102. doi: 10.1007/s12094-014-1236-0. Epub 2014 Oct 29. Review.

PMID:
25351170
50.

The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models.

Carnero A, Paramio JM.

Front Oncol. 2014 Sep 23;4:252. doi: 10.3389/fonc.2014.00252. eCollection 2014. Review.

Supplemental Content

Loading ...
Support Center